PL2276505T3 - Sprej do nosa lub krople do nosa do leczenia przeziębienia - Google Patents

Sprej do nosa lub krople do nosa do leczenia przeziębienia

Info

Publication number
PL2276505T3
PL2276505T3 PL09721305T PL09721305T PL2276505T3 PL 2276505 T3 PL2276505 T3 PL 2276505T3 PL 09721305 T PL09721305 T PL 09721305T PL 09721305 T PL09721305 T PL 09721305T PL 2276505 T3 PL2276505 T3 PL 2276505T3
Authority
PL
Poland
Prior art keywords
nasal
treatment
common cold
drops
spray
Prior art date
Application number
PL09721305T
Other languages
English (en)
Polish (pl)
Inventor
Krister Tano
Original Assignee
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karobio Ab filed Critical Karobio Ab
Publication of PL2276505T3 publication Critical patent/PL2276505T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09721305T 2008-03-20 2009-03-20 Sprej do nosa lub krople do nosa do leczenia przeziębienia PL2276505T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0800658 2008-03-20
EP09721305.2A EP2276505B1 (en) 2008-03-20 2009-03-20 Nasal spray or nasal drops for treatment of common cold
PCT/SE2009/050291 WO2009116944A1 (en) 2008-03-20 2009-03-20 Use of a substance for manufacturing of a medicament for treatment of common cold

Publications (1)

Publication Number Publication Date
PL2276505T3 true PL2276505T3 (pl) 2014-01-31

Family

ID=41091160

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09721305T PL2276505T3 (pl) 2008-03-20 2009-03-20 Sprej do nosa lub krople do nosa do leczenia przeziębienia

Country Status (8)

Country Link
US (1) US8895282B2 (enExample)
EP (1) EP2276505B1 (enExample)
JP (1) JP5558458B2 (enExample)
CN (1) CN101977625A (enExample)
DK (1) DK2276505T3 (enExample)
ES (1) ES2436037T3 (enExample)
PL (1) PL2276505T3 (enExample)
WO (1) WO2009116944A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
US10213491B2 (en) * 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
US20180280483A1 (en) * 2015-08-21 2018-10-04 Morinaga Milk Industry Co., Ltd. Agent for protecting upper respiratory tract and food or drink composition for protecting upper respiratory tract
CA3038590A1 (en) * 2016-10-06 2018-04-12 Matoke Holdings Limited Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN112105378B (zh) 2018-01-03 2025-03-11 宾夕法尼亚州研究基金会 作为新生儿抗惊厥药的葡萄糖氧化酶组合物
CN112351766A (zh) 2018-06-25 2021-02-09 璀昂芬制药公司 使用含锌的组合物抑制微生物感染的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1992014484A1 (en) 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
GB2285218A (en) * 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
GB9406075D0 (en) 1994-03-26 1994-05-18 Boots Co Plc Method of killing microorganisms
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1999002148A1 (en) * 1997-07-11 1999-01-21 The Johns Hopkins University School Of Medicine Nitric oxide inhibits rhinovirus infection
DE29723959U1 (de) 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
AU7584500A (en) 1999-09-17 2001-04-17 Smithkline Beecham Corporation Use of csaids in rhinovirus infection
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US6214339B1 (en) 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
AR030753A1 (es) 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
SE0200876L (sv) 2002-03-22 2003-09-23 Krister Tano Nässpray mot öroninflammationer
CN1408358A (zh) * 2002-09-20 2003-04-09 高艺歌 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
WO2005113026A2 (en) 2004-04-22 2005-12-01 Medical Discoveries, Inc. Method of treating respiratory disorders and airway inflammation
US20070026085A1 (en) 2005-07-26 2007-02-01 Global Life Technologies Corp. Antimicrobial and antiviral composition
BRPI0617481A2 (pt) 2005-10-21 2011-07-26 Danisco composiÇço que compreende um sistema enzimÁtico acoplado

Also Published As

Publication number Publication date
JP5558458B2 (ja) 2014-07-23
EP2276505B1 (en) 2013-09-18
JP2011515391A (ja) 2011-05-19
DK2276505T3 (da) 2013-11-25
EP2276505A1 (en) 2011-01-26
US8895282B2 (en) 2014-11-25
EP2276505A4 (en) 2011-06-22
CN101977625A (zh) 2011-02-16
ES2436037T3 (es) 2013-12-26
US20110044966A1 (en) 2011-02-24
WO2009116944A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
EP2049035A4 (en) NASAL TISSUE TREATMENT SYSTEMS
GB0703909D0 (en) Treatment of anxiety disorders
EP2182952A4 (en) TREATMENT OF POST-TRAUMATIC STRESS DISORDER
IL194189A0 (en) Combination treatment of metabolic disorders
SI2427193T1 (sl) Uporaba inhibitorjev PDE7 za zdravljenje motenj gibanja
ZA201107449B (en) Compounds for the treatment of metabolic disorders
PL2061501T3 (pl) Sposób leczenia zaburzeń oddechowych
EP2120930A4 (en) USE OF CHROMIHISTIDINATE FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES
PT2247297T (pt) Tratamento terapêutico para estados pulmonares
ZA201107446B (en) Compounds for the treatment of metabolic disorders
ZA201107445B (en) Compound for the treatment of metabolic disorders
PL2276505T3 (pl) Sprej do nosa lub krople do nosa do leczenia przeziębienia
GB0909297D0 (en) Composition for the treatment of skin conditions
GB0809476D0 (en) Treatment of neurodegenerative disorders
IL210558A0 (en) Treatment of anxiety disorders
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
GB0723100D0 (en) Treatment of HFnEF
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
ZA201104663B (en) Sulfonamide compounds for the treatment of respiratory disorders
EP2240024A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
GB0811625D0 (en) Treatment of epithelial fragility disorders
ZA201100490B (en) Treatment of thrombocytopenia
GB0814043D0 (en) The treatment of skin disorders
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis
TWM301061U (en) Structure of nasal sprayer